Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: LCAT stimulants - Amgen

Drug Profile

Research programme: LCAT stimulants - Amgen

Alternative Names: LCAT activators - Amgen; Lecithin cholesterol acyltransferase activators - Amgen; Phosphatidylcholine sterol O acyltransferase stimulants - Amgen; Pyrazine analogues as LCAT activators - Amgen

Latest Information Update: 15 Sep 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Amgen
  • Class Pyrazines; Small molecules
  • Mechanism of Action Enzyme stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Atherosclerosis; Coronary disorders

Most Recent Events

  • 15 Sep 2016 Discontinued - Preclinical for Atherosclerosis in USA (unspecified route) (Amgen pipeline; September 2016)
  • 15 Sep 2016 Discontinued - Preclinical for Coronary disorders in USA (unspecified route) (Amgen pipeline; September 2016)
  • 10 Apr 2008 Preclinical trials in Atherosclerosis in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top